A Novel Phenotype-Based Drug-Induced Liver Injury Causality Assessment Tool (DILI-CAT) Allows for Signal Confirmation in Early Drug Development
Author
Tillmann, Hans L.; Hermann, Richard P.; Rockey, Don C.; Suzuki, Ayako; Merz, Michael
Date
2022
Citation:
APA:
Tillmann, Hans L., & Hermann, Richard P., & Rockey, Don C., & Suzuki, Ayako, & Merz, Michael. (January 2022).
A Novel Phenotype-Based Drug-Induced Liver Injury Causality Assessment Tool (DILI-CAT) Allows for Signal Confirmation in Early Drug Development.
,
(),
-
. Retrieved from
http://hdl.handle.net/10342/11685
MLA:
Tillmann, Hans L., and Hermann, Richard P., and Rockey, Don C., and Suzuki, Ayako, and Merz, Michael.
"A Novel Phenotype-Based Drug-Induced Liver Injury Causality Assessment Tool (DILI-CAT) Allows for Signal Confirmation in Early Drug Development". .
. (),
January 2022.
April 25, 2024.
http://hdl.handle.net/10342/11685.
Chicago:
Tillmann, Hans L. and Hermann, Richard P. and Rockey, Don C. and Suzuki, Ayako and Merz, Michael,
"A Novel Phenotype-Based Drug-Induced Liver Injury Causality Assessment Tool (DILI-CAT) Allows for Signal Confirmation in Early Drug Development," , no.
(January 2022),
http://hdl.handle.net/10342/11685 (accessed
April 25, 2024).
AMA:
Tillmann, Hans L., Hermann, Richard P., Rockey, Don C., Suzuki, Ayako, Merz, Michael.
A Novel Phenotype-Based Drug-Induced Liver Injury Causality Assessment Tool (DILI-CAT) Allows for Signal Confirmation in Early Drug Development. .
January 2022;
():
.
http://hdl.handle.net/10342/11685. Accessed
April 25, 2024.